Eukaryotes Draw Origins Challenge, Polygenic Scores Boost Steroid Side Effects Prediction, Immune Genes Drive Rare Neurodegeneration, Joint Breakthrough Regenerates Cartilage, and more...
Jun 15, 2026•11 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
(0:10): New Study Reveals Eukaryotes' Complex Multi-Source Origins, Challenging Single-Endosymbiosis Theory
(2:49): Polygenic Risk Scores Enhance Prediction of Steroid Side Effects, Paving Way for Personalized Medicine
(4:32): CD99L2 Gene Identified as Key Player in Rare Spastic Ataxia; Study Links Immune Genes to Neurodegeneration
(6:23): Breakthrough in Joint Repair: Enzyme Blockade Regenerates Cartilage, Halts Osteoarthritis Progression
(8:23): Legend Biotech Unveils Promising Clinical Data for LB2501 CAR‑T Therapy in B-Cell Non‑Hodgkin Lymphoma
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Mirage News
(2:49): Polygenic Risk Scores Enhance Prediction of Steroid Side Effects, Paving Way for Personalized Medicine
(4:32): CD99L2 Gene Identified as Key Player in Rare Spastic Ataxia; Study Links Immune Genes to Neurodegeneration
(6:23): Breakthrough in Joint Repair: Enzyme Blockade Regenerates Cartilage, Halts Osteoarthritis Progression
(8:23): Legend Biotech Unveils Promising Clinical Data for LB2501 CAR‑T Therapy in B-Cell Non‑Hodgkin Lymphoma
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: Mirage News
For the best experience, listen in Metacast app for iOS or Android